Ident. | Authors (with country if any) | Title |
---|
000213 |
Fabrizio Stocchi [Italie] ; Luigi Giorgi [Royaume-Uni] ; Brian Hunter [Royaume-Uni] ; Anthony Hv Schapira [Royaume-Uni] | PREPARED: Comparison of prolonged and immediate release ropinirole in advanced Parkinson's disease |
000333 |
Olivier Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
000349 |
Robert A. Hauser [États-Unis] ; Aaron L. Ellenbogen [États-Unis] ; Leo Verhagen Metman [États-Unis] ; Ann Hsu [États-Unis] ; Martin J. O'Connell [États-Unis] ; Nishit B. Modi [États-Unis] ; Hsuan-Ming Yao [États-Unis] ; Sherron H. Kell [États-Unis] ; Suneel K. Gupta [États-Unis] | Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease |
000549 |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
000611 |
Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France] | Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study |
000638 |
Iria Cabo L Pez [Espagne] ; Pedro J. García Ruiz [Espagne] ; Silvia Vázquez Fernández Del Pozo [Espagne] ; Vicenta Sánchez Bernardos [Espagne] | Motor complications in Parkinson's disease: Ten year follow‐up study |
000652 |
Emanuele Cereda [Italie] ; Michela Barichella [Italie] ; Carlo Pedrolli [Italie] ; Gianni Pezzoli [Italie] | Low‐protein and protein‐redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review |
000654 |
Asha Kishore [Inde] ; Ravimohan Rao [Inde] ; Syam Krishnan [Inde] ; Dilip Panikar [Inde] ; Gangadhara Sarma [Inde] ; Mathuranath Pavagada Sivasanakaran [Inde] ; Sankara Sarma [Inde] | Long‐term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience |
000736 |
Bonnie P. Hersh [États-Unis] ; Nancy L. Earl [États-Unis] ; Robert A. Hauser [États-Unis] ; Mark Stacy [États-Unis] | Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations |
000968 |
Cecilia M. Peralta [Autriche, Argentine] ; Birgit Frauscher [Autriche] ; Klaus Seppi [Autriche] ; Elisabeth Wolf [Autriche] ; Gregor K. Wenning [Autriche] ; Birgit Högl [Autriche] ; Werner Poewe [Autriche] | Restless legs syndrome in Parkinson's disease |
000C36 |
Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis] | Treatment of levodopa‐induced motor complications |
000C63 |
Robert A. Hauser [États-Unis] ; Lisa M. Shulman [États-Unis] ; Joel M. Trugman [États-Unis] ; John W. Roberts [États-Unis] ; Akihisa Mori [Japon] ; Rocco Ballerini [États-Unis] ; Neil M. Sussman [États-Unis] | Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations |
000D09 |
John G. Nutt [États-Unis] | Pharmacokinetics and pharmacodynamics of levodopa |
000D62 |
P. Damier [France] ; F. Viallet [France] ; M. Ziegler [France] ; I. Bourdeix [France] ; K. Rerat [France] | Levodopa/DDCI and entacapone is the preferred treatment for Parkinson’s disease patients with motor fluctuations in routine practice: a retrospective, observational analysis of a large French cohort |
000D83 |
Won Yong Lee [Corée du Sud] ; Won Tae Yoon [Corée du Sud] ; Hee Young Shin [Corée du Sud] ; Seong Hee Jeon [Corée du Sud] ; Poong-Lyul Rhee [Corée du Sud] | Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease |
000E08 |
Pedro J. García Ruiz [Espagne] ; Ángel Sesar Ignacio [Espagne] ; Bego A Ares Pensado [Espagne] ; Alfonso Castro García [Espagne] ; Fernando Alonso Frech [Espagne] ; Mercedes Álvarez L Pez [Espagne] ; José Arbelo González [Espagne] ; Joan Baiges Octavio [Espagne] ; Juan Andrés Burguera Hernández [Espagne] ; Matilde Calopa Garriga [Espagne] ; Dulce Campos Blanco [Espagne] ; Belén Casta O García [Espagne] ; Manuel Carballo Cordero [Espagne] ; José Chac N Pe A [Espagne] ; Anna Espino Ibá Ez [Espagne] ; Aránzazu Gorospe Onisalde [Espagne] ; Santiago Giménez-Roldán [Espagne] ; Pilar Granés Ibá Ez [Espagne] ; Jorge Hernández Vara [Espagne] ; Ram N Ibá Ez Alonso [Espagne] ; Félix Javier Jiménez Jiménez [Espagne] ; Jerzy Krupinski [Espagne] ; Jaime Kulisevsky Bojarsky [Espagne] ; Inés Legarda Ramírez [Espagne] ; Elena Lezcano García [Espagne] ; Juan Carlos Martínez-Castrillo [Espagne] ; Dolores Mateo González [Espagne] ; Francesc Miquel Rodríguez [Espagne] ; Pablo Mir [Espagne] ; Elena Mu Oz Fargas [Espagne] ; José Obeso Inchausti [Espagne] ; Jesús Olivares Romero [Espagne] ; José Olivé Plana [Espagne] ; Pilar Otermin Vallejo [Espagne] ; Berta Pascual Sedano [Espagne] ; Víctor Pérez De Colosía Rama [Espagne] ; Isabel Pérez L Pez-Fraile [Espagne] ; Albert Planas Comes [Espagne] ; Víctor Puente Periz [Espagne] ; María Cruz Rodríguez Oroz [Espagne] ; Dolores Sevillano García [Espagne] ; Pilar Solís Pérez [Espagne] ; José Suárez Mu Oz [Espagne] ; Julia Vaamonde Gamo [Espagne] ; Caridad Valero Merino [Espagne] ; Francesc Valldeoriola Serra [Espagne] ; José Miguel Velázquez Pérez [Espagne] ; Rosa Yá Ez Ba A [Espagne] ; Ivana Zamarbide Capdepon [Espagne] | Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study |
000F56 |
V. Pursiainen [Finlande] ; T. J. Korpelainen [Finlande] ; H. T. Haapaniemi [Finlande] ; A. K. Sotaniemi [Finlande] ; V. V. Myllyl [Finlande] | Selegiline and blood pressure in patients with Parkinson's disease |
001058 |
| Entacapone to tolcapone switch: Multicenter double‐blind, randomized, active‐controlled trial in advanced Parkinson's disease |
001169 |
Obering [États-Unis] ; Chen ; Swope [États-Unis] | Update on Apomorphine for the Rapid Treatment of Hypomobility (“Off”) Episodes in Parkinson's Disease |
001211 |
F. Stocchi [Italie] | Rasagiline: defining the role of a novel therapy in the treatment of Parkinson's disease |
001309 |
P. Odin [Allemagne] ; C. Oehlwein [Allemagne] ; A. Storch [Allemagne] ; U. Polzer [Allemagne] ; G. Werner [Allemagne] ; R. Renner [Allemagne] ; M. Shing [Allemagne] ; A. Ludolph [Allemagne] ; P. Schüler [Allemagne] | Efficacy and safety of high‐dose cabergoline in Parkinson's disease |
001360 |
Noël L. W. Keijsers [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Stan C. A. M. Gielen [Pays-Bas] | Ambulatory motor assessment in Parkinson's disease |
001481 |
Mark Stacy [États-Unis] ; Annette Bowron [Royaume-Uni] ; Mark Guttman [Canada] ; Robert Hauser [États-Unis] ; Kim Hughes [Royaume-Uni] ; Jan Petter Larsen [Norvège] ; Peter Lewitt [États-Unis] ; Wolfgang Oertel [Allemagne] ; Niall Quinn [Royaume-Uni] ; Kapil Sethi [États-Unis] ; Fabrizio Stocchi [Italie] | Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment |
001557 |
Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis] | Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3‐month, randomized, placebo‐controlled study |
001584 |
Connie Marras [Canada] ; Anthony Lang [Canada] ; Murray Krahn [Canada] ; George Tomlinson [Canada] ; Gary Naglie [Canada] | Quality of life in early Parkinson's disease: Impact of dyskinesias and motor fluctuations |
001A69 |
J. Eric Ahlskog [États-Unis] ; Manfred D. Muenter [États-Unis] | Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature |
001C39 |
Anette Schrag [Royaume-Uni] ; Niall Quinn [Royaume-Uni] | Dyskinesias and motor fluctuations in Parkinson's disease |
002357 |
D. Muguet [France] ; E. Broussolle [France] ; G. Chazot [France] | Apomorphine in patients with Parkinson's disease |